AB&B BIO-TECH-B (02627.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec8

China Wisdom Biologics-B initiates Phase III clinical trial for freeze-dried human rabies vaccine

09:34

Sep4

Zhonghui Biopharma's Quadrivalent Influenza Vaccine Approved for All Age Groups

00:49

Aug28

AB&B BIO-TECH-B released FY2025 Semi-Annual Earnings on August 28, 2025 (BJT) with actual revenue of HKD 77.01 M and EPS of HKD -0.3654

15:00

AB&B BIO-TECH-B released FY2025 Q2 earnings on August 28, 2025 (BJT) with actual revenue of HKD 77.39 M and EPS of HKD -0.1039

15:00

AB&B BIO-TECH-B released FY2024 Semi-Annual Earnings on August 28, 2025 (BJT), with actual revenue of HKD 7.53 M and EPS of HKD -0.467

15:00

AB&B BIO-TECH-B released FY2024 Q2 earnings on August 28, 2025 (BJT) with actual revenue of HKD 7.169 M and EPS of HKD -0.276

15:00

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 77.39 M, Net Income -37.43 M, EPS -0.1039

Aug11

IPO(CST)

Listing Price HKD 12.9

Jul30

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 442.31 K, Net Income -93.51 M, EPS -0.2597

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change